Abstract
Numerous approaches have been used to track COVID-19 trends, from wastewater surveillance to laboratory reporting of diagnostic test results. However, questions remain about how best to focus surveillance efforts during and after public health emergencies. Using an archive of SARS-CoV-2 surveillance data, we reconstructed seven real-time surveillance indicators and assessed their performance as predictors of 7-day moving average COVID-19 hospital admissions in Colorado from October 2020 to March 2024. Models were constructed using neural network models and Ordinary Least Squares regression. We found that hospital census data, emergency-department based syndromic surveillance, and daily COVID-19 hospital admissions were the best indicators of COVID-19 hospital demand in Colorado during the public health emergency (PHE) (October 2020 – May 2023) and after (May 2023 – March 2024). The removal of wastewater from our multi-indicator models resulted in a decrease in model performance, indicating that wastewater provides important and unique information. By contrast, capacity to predict COVID-19 hospital admissions was not meaningfully reduced when sentinel test positivity, statewide test positivity, and/or case report data were dropped from our prediction models during and after the PHE. These findings underscore the importance of hospital-based reporting for monitoring COVID-19 hospital admissions, and, conversely, suggest that case reporting and percent positivity are not essential to monitoring COVID-19 hospitalizations in Colorado.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was supported in part by funding from the Colorado Department of Public Health & Environment.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data availability
All data used in these analyses was obtained from third parties or public resources. Request for access to these data can be directed to the following parties: the Colorado Department of Public Health & Environment (syndromic surveillance, hospital census, case reports, wastewater and sentinel positivity data); and HHS Protect (hospital admissions data).
